Diverse Roles of Neurotensin Agonists in the Central Nervous System
Open Access
- 1 January 2013
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 4, 36
- https://doi.org/10.3389/fendo.2013.00036
Abstract
Neurotensin (NT) is a tridecapeptide that is found in the central nervous system (CNS) and the gastrointestinal tract. NT behaves as a neurotransmitter in the brain and as a hormone in the gut. Additionally, NT acts as a neuromodulator to several neurotransmitter systems including dopaminergic, sertonergic, GABAergic, glutamatergic, and cholinergic systems. Due to its association with such a wide variety of neurotransmitters, NT has been implicated in the pathophysiology of several CNS disorders such as schizophrenia, drug abuse, Parkinson’s disease (PD), pain, central control of blood pressure, eating disorders, as well as, cancer and inflammation. The present review will focus on the role that NT and its analogs play in schizophrenia, endocrine function, pain, psychostimulant abuse, and PD.Keywords
This publication has 154 references indexed in Scilit:
- The role of NTS2 in the development of tolerance to NT69L in mouse models for hypothermia and thermal analgesiaBehavioural Brain Research, 2011
- Leptin Action via Neurotensin Neurons Controls Orexin, the Mesolimbic Dopamine System and Energy BalanceCell Metabolism, 2011
- The neurotensin-1 receptor agonist PD149163 inhibits conditioned avoidance responding without producing catalepsy in ratsEuropean Neuropsychopharmacology, 2011
- Similarities in the behavior and molecular deficits in the frontal cortex between the neurotensin receptor subtype 1 knockout mice and chronic phencyclidine-treated mice: Relevance to schizophreniaNeurobiology of Disease, 2010
- Effect of amphetamine on extracellular concentrations of amino acids in striatum in neurotensin subtype 1 and 2 receptor null mice: A possible interaction between neurotensin receptors and amino acid systems for study of schizophreniaNeuropharmacology, 2010
- The novel neurotensin analog NT69L blocks phencyclidine (PCP)-induced increases in locomotor activity and PCP-induced increases in monoamine and amino acids levels in the medial prefrontal cortexBrain Research, 2009
- NT79: A novel neurotensin analog with selective behavioral effectsBrain Research, 2009
- Chronic NT69L potently prevents drug-induced disruption of prepulse inhibition without causing toleranceBehavioural Brain Research, 2009
- The acute and subchronic effects of a brain-penetrating, neurotensin-1 receptor agonist on feeding, body weight and temperatureNeuropharmacology, 2009
- The reversal of amphetamine-induced locomotor activation by a selective neurotensin-1 receptor agonist does not exhibit tolerancePsychopharmacology, 2008